Register entry
- Registered sites
- 6
- Active NDC listings
- 46
- Live patents
- 0
- Countries
- 4
- Base
- United States
Authorisation
Registered operations
Analytical testing5Active ingredient (API) manufacture2Labelling6Finished drug manufacture6Packaging6
Sites
Registered establishments
6| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| KVP Pharma Veterin�r Produkte GmbHRegistrant: Elanco US Inc. | Projensdorfer Strasse 324, Kiel, 24106, Germany (DEU) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3004159824320324445 |
| Elanco France SASRegistrant: Elanco US Inc. | 26 Rue De La Chapelle, Huningue, 68330, France (FRA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002638215736833104 |
| Elanco UK AH LimitedRegistrant: Elanco US Inc. | Fleming Road, Speke, Liverpool L24 9LN, United Kingdom (GBR) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3003701830230761368 |
| Elanco Clinton LaboratoriesRegistrant: Elanco US Inc. | 10500 S. State Road 63, Clinton, Indiana (IN) 47842, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 1820381039138631 |
| Ivy Animal Health, Inc.Registrant: Elanco US Inc. | 10850 Lakeview Ave., Lenexa, Kansas (KS) 66219, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3013503383080698078 |
| Ivy Animal Health, Inc.Registrant: Elanco US Inc. | 8857 Bond Street, Overland Park, Kansas (KS) 66214, United States (USA) | Labelling, Finished drug manufacture, Packaging | 1910028088106096 |
Catalogue
Drug listings by form and route
4646 active NDC listings: 41 drug for further processing, 5 animal drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 34, EXPORT ONLY 12.
| Dosage form | NDCs |
|---|---|
| tablet, chewable | 21 |
| tablet | 16 |
| injection | 6 |
| implant | 3 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| elanco us inc. | 46 |
Catalogue
Marketed products
46| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Butafosfan and Cyanocobalamin | injection | 58198-4682EXPORT ONLY |
| - | Butafosfan and Cyanocobalamin | injection | 58198-7646EXPORT ONLY |
| - | ENROFLOXACIN | injection | 58198-0675EXPORT ONLY |
| - | ENROFLOXACIN | injection | 58198-6086EXPORT ONLY |
| - | Enrofloxacin | injection | 58198-0671EXPORT ONLY |
| - | Pradofloxacin | tablet | 58198-6452EXPORT ONLY |
| - | Pradofloxacin | tablet | 58198-6460EXPORT ONLY |
| - | Pradofloxacin | tablet | 58198-6479EXPORT ONLY |
| - | XYLAZINE HYDROCHLORIDE | injection | 58198-6584EXPORT ONLY |
| - | estradiol hemihydrate, trenbolone acetate and tylosin tartrate | implant | 58198-1001EXPORT ONLY |
| - | ilunocitinib | tablet | 58198-5361DRUG FOR FURTHER PROCESSING |
| - | ilunocitinib | tablet | 58198-5371DRUG FOR FURTHER PROCESSING |
| - | ilunocitinib | tablet | 58198-5381DRUG FOR FURTHER PROCESSING |
| - | ilunocitinib | tablet | 58198-5391DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4511DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4521DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4541DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4561DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4581DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4872DRUG FOR FURTHER PROCESSING |
| - | lotilaner | tablet, chewable | 58198-4881DRUG FOR FURTHER PROCESSING |
| - | lotilaner, moxidectin, praziquantel, and pyrantel | tablet, chewable | 58198-8251DRUG FOR FURTHER PROCESSING |
| - | lotilaner, moxidectin, praziquantel, and pyrantel | tablet, chewable | 58198-8261DRUG FOR FURTHER PROCESSING |
| - | lotilaner, moxidectin, praziquantel, and pyrantel | tablet, chewable | 58198-8271DRUG FOR FURTHER PROCESSING |
| - | lotilaner, moxidectin, praziquantel, and pyrantel | tablet, chewable | 58198-8281DRUG FOR FURTHER PROCESSING |
| - | lotilaner, moxidectin, praziquantel, and pyrantel | tablet, chewable | 58198-8291DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime | tablet | 58198-4850DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime | tablet | 58198-4855DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime | tablet | 58198-4860DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime | tablet | 58198-4865DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime and praziquantel | tablet, chewable | 58198-4401DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime and praziquantel | tablet, chewable | 58198-4441DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime and praziquantel | tablet, chewable | 58198-4461DRUG FOR FURTHER PROCESSING |
| - | milbemycin oxime and praziquantel | tablet, chewable | 58198-4481DRUG FOR FURTHER PROCESSING |
| - | progesterone, estradiol benzoate and tylosin tartrate | implant | 58198-0329EXPORT ONLY |
| - | spinosad | tablet, chewable | 58198-2224DRUG FOR FURTHER PROCESSING |
| - | spinosad | tablet, chewable | 58198-2234DRUG FOR FURTHER PROCESSING |
| - | spinosad | tablet, chewable | 58198-2244DRUG FOR FURTHER PROCESSING |
| - | spinosad | tablet, chewable | 58198-2254DRUG FOR FURTHER PROCESSING |
| - | spinosad | tablet, chewable | 58198-2274DRUG FOR FURTHER PROCESSING |
| - | spinosad and milbemycin oxime | tablet | 58198-3324DRUG FOR FURTHER PROCESSING |
| - | spinosad and milbemycin oxime | tablet | 58198-3334DRUG FOR FURTHER PROCESSING |
| - | spinosad and milbemycin oxime | tablet | 58198-3344DRUG FOR FURTHER PROCESSING |
| - | spinosad and milbemycin oxime | tablet | 58198-3354DRUG FOR FURTHER PROCESSING |
| - | spinosad and milbemycin oxime | tablet | 58198-3364DRUG FOR FURTHER PROCESSING |
| - | trenbolone acetate, estradiol and tylosin tartrate | implant | 58198-0359EXPORT ONLY |
Neighbours
Registered in the same town
5- PETNET Solutions, Inc.OVERLAND PARK, KS
- Novartis Pharmaceuticals CorporationHuningue, FRA
- Ferring Pharmaceuticals Inc.Kiel, DEU
- Adare Pharmaceuticals USA, Inc.Lenexa, KS
- BF ASCHER AND CO INCLENEXA, KS
Compare
Comparable companies in United States
- Fresenius Kabi USA, LLC6 sites · 561 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Ecolab Inc.6 sites · 105 NDC
- Eisai Inc.6 sites · 51 NDC
- BASF Corporation6 sites · 24 NDC
- Fresenius Medical Care Renal Therapies Group, LLC6 sites · 7 NDC
- Holston Gases, Inc.6 sites · 4 NDC
- General Distributing Co.6 sites · 3 NDC
- Reliant Holdings, Ltd6 sites · 1 NDC
- TransOx, Inc.6 sites · 1 NDC
Enquiry
Common questions
- Is Elanco US Inc. FDA approved?
- Elanco US Inc. holds 6 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Elanco US Inc.'s drugs manufactured?
- At registered sites in Germany, France, the United Kingdom, the United States. The FDA register lists Kiel; Huningue; Speke; Clinton, IN; Lenexa, KS; Overland Park, KS. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
- What drugs does Elanco US Inc. make?
- 46 products are listed under Elanco US Inc. in the openFDA NDC Directory, most often as tablet, chewable; tablet; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.